- Home
- KEYS vs ILMN Comparison
KEYS vs ILMN Comparison
Compare KEYS & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KEYS
- ILMN
- Stock Information
- Founded
- KEYS 1939
- ILMN 1998
- Country
- KEYS United States
- ILMN United States
- Employees
- KEYS N/A
- ILMN N/A
- Industry
- KEYS Industrial Machinery/Components
- ILMN Medical Specialities
- Sector
- KEYS Industrials
- ILMN Health Care
- Exchange
- KEYS Nasdaq
- ILMN Nasdaq
- Market Cap
- KEYS 29.0B
- ILMN 23.6B
- IPO Year
- KEYS N/A
- ILMN 2000
- Fundamental
- Price
- KEYS $163.29
- ILMN $136.02
- Analyst Decision
- KEYS Buy
- ILMN Buy
- Analyst Count
- KEYS 10
- ILMN 19
- Target Price
- KEYS $180.80
- ILMN $162.67
- AVG Volume (30 Days)
- KEYS 1.5M
- ILMN 2.4M
- Earning Date
- KEYS 01-29-2025
- ILMN 02-06-2025
- Dividend Yield
- KEYS N/A
- ILMN N/A
- EPS Growth
- KEYS N/A
- ILMN N/A
- EPS
- KEYS 3.51
- ILMN N/A
- Revenue
- KEYS $4,979,000,000.00
- ILMN $4,390,000,000.00
- Revenue This Year
- KEYS $7.51
- ILMN N/A
- Revenue Next Year
- KEYS $6.86
- ILMN $4.05
- P/E Ratio
- KEYS $46.50
- ILMN N/A
- Revenue Growth
- KEYS N/A
- ILMN N/A
- 52 Week Low
- KEYS $119.72
- ILMN $97.36
- 52 Week High
- KEYS $175.39
- ILMN $156.66
- Technical
- Relative Strength Index (RSI)
- KEYS 47.21
- ILMN 41.25
- Support Level
- KEYS $158.82
- ILMN $130.31
- Resistance Level
- KEYS $172.24
- ILMN $148.51
- Average True Range (ATR)
- KEYS 3.56
- ILMN 5.58
- MACD
- KEYS -1.48
- ILMN -1.08
- Stochastic Oscillator
- KEYS 29.34
- ILMN 26.63
About KEYS Keysight Technologies Inc.
Keysight Technologies is a leader in the field of testing and measurement, helping electronics OEMs and suppliers alike bring products to market to fit industry standards and specifications. Keysight specializes in the communications market, but also supplies into the government, automotive, industrial, and semiconductor manufacturing markets. Keysight's solutions include testing tools, analytical software, and services. The firm's stated objective is to reduce time to market and improve efficiency at its more than 30,000 customers.
About ILMN Illumina Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2023 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.